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Abstract 
Background: Extracellular vesicles (EVs) are small membrane-bound vesicles of growing 
interest in vetetinary parasitology. The aim of the present report was to provide the 
first isolation, quantification and protein characterization of EVs from buffalo (Bubalus 
bubalis) sera infected with Theileria spp.
Methods: Infected animals were identified through optical microscopy and PCR. EVs 
were isolated from buffalo sera by size-exclusion chromatography and characterized 
using western blotting analysis, nanoparticle tracking analysis and transmission electron 
microscopy. Subsequently, the proteins from isolated vesicles were characterized by 
mass spectrometry.
Results: EVs from buffalo sera have shown sizes in the 124-140 nm range and 306 
proteins were characterized. The protein-protein interaction analysis has evidenced 
biological processes and molecular function associated with signal transduction, binding, 
regulation of metabolic processes, transport, catalytic activity and response to acute 
stress. Five proteins have been shown to be differentially expressed between the control 
group and that infected with Theileria spp., all acting in the oxidative stress pathway. 
Conclusions: EVs from buffaloes infected with Theileria spp. were successfully isolated 
and characterized. This is an advance in the knowledge of host-parasite relationship 
that contributes to the understanding of host immune response and theileriosis evasion 
mechanisms. These findings may pave the way for searching new EVs candidate-markers 
for a better production of safe biological products derived from buffaloes. 
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Background
Extracellular vesicles (EVs) are small vesicles known to play major 
roles in intercellular communication [1]. They are classified as 
small (SEVs) and large (LEVs) EVs based on their size, biogenesis 
and composition [2]. Exosomes, considered as SEVs, are 40-
150-nm diameter vesicles originated in endosomal pathway. 
They emerge from budding of endosomal membranes, forming 
multivesicular endosomes (MVEs), further maturated to late 
endosomes or multivesicular bodies (MVBs) containing the 
intraluminal vesicles [3].
Exosomes have a lipid bilayer membrane enriched with host 
specific proteins, besides mRNA and microRNA that confers to 
them the capacity of transporting information from origin cell 
to a specific target [4]. These SEVs are considered as promising 
potential biomarkers in diagnosis, since their molecular 
composition reflects a “signature” of the origin cell [5,6]. In 
this way, after studies in tumor development [7], SEVs became 
attractive targets in several diseases, given their increased 
secretion in this context [8]. 
Parasitic diseases use vesicles to communicate with the host 
cells [9], where infected cells have the ability to change the 
composition and function of these released vesicles during host-
parasite interactions, thus mediating the disease development 
[10]. Apicomplexa comprises a diverse group of obligate 
intracellular parasites, most known species are pathogens of 
humans and domestic animals. The hemoparasites Theileria 
spp. cause tick-borne diseases of great health and economic 
impacts, especially in tropical areas [11–15]. 
The potential clinical uses of EVs in human Apicomplexa 
infections have been extensively described [16,17]. However, 
there is limited data about the use of EVs for diseases affecting 
domestic and farm animals. The role of EVs in apicomplexan 
parasite infections is a prospective field, with great potential for 
biotechnological development targeting clinical and economic 
interests for veterinary medicine [18,19]. 
There is a need for innovative approaches that focus on 
theileriosis since there is no efficient treatment against it, despite 
its economic impact. EVs have been explored as a promising 
target to study parasite-host interactions in a level never accessed 
before. They represent a valuable source for new vaccines and 
diagnostic tools for neglected tropical and vector-borne diseases 
conjointly for animal health and production [20–22]. 
Buffaloes from Bubalus bubalis species have gained relevance 
in the world economy due to the quality of their milk, meat, 
and leather, in addition of being important donors of blood 
components. A heterologous fibrin sealant was developed from 
the fibrinogen-rich cryoprecipitate of buffalo blood [23,24], 
which has been used in several clinical applications such as in 
the treatment of chronic venous ulcers [25]. The use of fibrin 
has incresed due to its biological properties in skin tissue 
regeneration as well as wound healing processes [26]. 
A number of strategies employing synthetic polymers such 
as polyethylene glycol [27] and engineered hemostatic polymer 
[28] were successfully developed and showed promising results 
in the reduction of dermal lesions and standard management of 
acute bleeding in congenital and acquired bleeding disorders. 
Many groups of researchers, including ours, support the idea 
that applying EVs as an innovative diagnostic system can be a 
breakthrough in veterinary medicine such as the application 
of synthetic polymers in human medicine [29–31].
The use of proteomics to validate biomarkers in EVs in order 
to facilitate precise diagnosis can be a valuable tool in in the 
research of parasitic infections [32–34]. Most of proteomic 
investigations are directed to study milk for use in dairy products 
and in mastitis, while the investigations in parasitic diseases 
are still poorly described [35, 36]. The protozoan parasites have 
developed various strategies to overcome host cell protective 
mechanisms favoring their survival [37]. Among the strategies 
used by them, EVs gained attention as an important evasion 
system during parasite infection. 
The present study reports for the first time the isolation and 
characterization of EVs from buffalo serum, comparing the 
EV content from healthy animals, Theileria spp. positive and 
Theileria spp. positive after treatment with dibenzamidine 
diacetate. Additionally, we were able to identify and quantify 
possible biomarkers for Theileria spp. by using proteomic 
strategy.
Methods 
Animals and Biological Samples
Fifty-seven buffaloes of the Bubalus bubalis species, 29 males and 
28 females of the Murrah breed, of approximately 18 months of 
age, non-lactating, belonging to a private farm (latitude –22.8744 
and longitude –47.9964) were selected as blood donors for this 
study during the period of September 4, 2014 and March 27, 
2017. These animals were bred on pasture supplemented with 
corn silage (Zea maiz L.) and Tifton 85 hay (Cynodon spp.), 
with drinking water and ad libitum mineral salt. All buffalo 
management and health conditions, which include endo and 
exoparasite vaccination and control schemes, were carried out in 
accordance with the Brazilian National Animal Health Programs 
from the Ministry of Agriculture, Livestock and Supply (MAPA). 
Once anaplasmosis was detected in the buffalo herd, the animals 
were treated with dibenzamidine diacetate (Ganaseg® Plus, 
Brazil), according to the manufacturer’s instructions.
Buffaloes were divided into three groups: C – control animals 
or Theileria spp. negative animals; Th – Theileria spp. positive 
animals; ThT – treated animals or Theileria spp. negative animals 
after contact with the parasite and treatment with dibenzamidine 
diacetate (Ganaseg® Plus, Brazil). 
Sample Collection 
Serum samples were collected from buffaloes (Bubalus bubalis) 
of the Murrah breed from the jugular vein of the animals using 
sterile needles in tubes without anticoagulant. Serum samples 
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were obtained after centrifuging the tubes at 1,500 g for 15 min 
and stored in a freezer at –80oC [24]. 
Hemoparasite Culture
All blood samples were submitted to culture tubes containing 
5 mL of liver Infusion tryptose medium. Blood cultures were 
kept in an oven at 28-30ºC and after 15 days of inoculation, 
positive cultures for hemoparasites were confirmed by optical 
microscopy (1000x magnification). Theileria spp. was confirmed 
in positive cultures by using PCR [38]. 
Molecular Analysis
For DNA extraction, Illustra Blood Genomic Prep Mini 
Spin Kit (GE Healthcare, USA) was used as recommended 
by the manufacturer. DNA was quantified using NanoVue 
(GE Healthcare, USA) and PCR reactions were performed 
by employing the primers described by Cao et al. [39]. The 
outer primer, F1 (5′-GAAACGGCTACCACATCT-3′) and 
R1 (5′-AGTTTCCCCGTGTTGAGT-3′), amplified a 778-
bp fragment from the 18S rRNA gene, while the inner 
primer, F2 (5′-TTAAACCTCTTCCAGAGT-3′) and R2 
(5′-TCAGCCTTGCGACCATAC-3′), amplified a 581-bp 
fragment. The reaction was composed of 10 ng of genomic 
DNA, 1 µL of each primer (10 ρmol/µL), 7.5 µL of ultrapure water 
and 12.5 µL of the GoTaq® Green Master Mix (Promega, USA). 
Incubation was carried out in a Mastercycler Gradient Thermal 
Cycler (Eppendorf, Germany). The cycling profile consisted of 
an initial denaturation at 94ºC for 30 s, followed by 40 cycles of 
94ºC for 30 s, annealing at 63.5ºC for 30 s, extension at 72ºC for 
1 min and a final extension step at 72ºC for 5 min. The amplicons 
were visualized in a 1.5% electrophoresis gel stained with SYBR™ 
Gold nucleic acid gel stain (Life Technologies®, USA).
Vesicle Isolation and Purification
For the isolation of vesicles, 750 μL of serum samples were 
loaded onto Izon qEV size-exclusion chromatography columns 
pre-equilibrated with PBS buffer (Izon Science, UK) and eluted 
with PBS buffer according to manufacturer’s instructions. The 
columns contained a resin with a pore size of approximately 75 
nm, a bed volume of 10 mL, inner tube diameter of 15.6 mm 
and 3.0 ± 0.25 mL void volume. Columns were pre-filled with 
PBS, containing 0.05% sodium azide. After discarding the void 
volume of the column (3 mL), three fractions of each sample 
were collected (500 μL each). The protein concentration of each 
fraction was determined by BCA. 
For EVs characterization, the second and third fractions 
were submitted to western blotting analysis: 12 μg of proteins 
were separated on SDS-PAGE 10% [m/v] (VWR® Mini Vertical 
PAGE System, UK), transferred to a nitrocellulose membrane 
(OmniPAGE Mini electroblotting system, Cleaver Scientific, UK) 
[40], and blocked for 1 h at room temperature with blocking buffer 
(1% [m/v] non-fat milk and 0.2% [m/v] I-block protein-based 
blocking reagent (Applied Biosystems) dissolved in Tris-buffered 
saline with 0.1% (v/v) Tween-20 (TBST). Western blotting was 
performed using the primary antibodies anti-flotillin-1 and 
anti-CD9 (anti-flotillin-1 ABIN5552770 and anti- bovine CD9 
ABIN94242 from Antibodies-online, Aachen, Germany) diluted 
at 1:500 and raised in goat and mouse, respectively. 
After incubation with the primary antibodies, the membrane 
was washed three times with TBS-T buffer, and further incubated 
for 1h at room temperature with horseradish peroxidase-
conjugated secondary antibodies for anti-f lotilin-1 and 
raised in mouse for anti-CD9 (diluted at 1:5000, Santa Cruz 
Biotechnology, Inc.). Membranes were imaged in LI-COR 
Odissey chemiluminescence and fluorescence imager (LI-COR 
Biosciences, USA). The bands present on membrane images were 
quantified by densitometric analysis using freeware ImageJ [41].
EV Characterization
In order to perform the characterization of isolated EV fractions 
nanoparticle tracking analysis (NTA) and transmission electron 
microscopy (TEM) were used. In NTA the EV suspensions were 
diluted in PBS buffer and analyzed in terms of nanoparticle size 
using a NS300 NanoSight LM10 (Malvern Instruments GmbH 
Ltda). Samples were introduced manually into the chamber 
through sterile syringes, and three videos of 30 s each were 
captured, with approximately 2000 tracks counted in each 
measure, at room temperature [42]. For TEM, the EV fractions 
were diluted 1:10 in PBS, applied onto a 200-mesh carbon-coated 
grid for 7 min at room temperature, thereafter stained with 
1.75% (v/v) uranyl acetate and washed in by sterile H2O. The 
grids were observed using a transmission electron microscope 
JEM 1400 (Jeol Ltd., Japan) operated at 80 kV [43].
Proteomic Analysis 
Twelve micrograms of total proteins from samples were diluted 
to a volume of 50 μL using 0.1 M triethyl ammonium bicarbonate 
(TEAB, Thermo Scientific, USA), reduced by adding 2.5 μL of 
200 mM DTT (60 min, 55°C) (Sigma Aldrich, USA), alkylated 
by adding 2.5 μL of 375 mM Iodoacetamide (30 min, room 
temperature in the dark) (Sigma Aldrich, USA) and precipitated 
with acetone (300 μL) overnight at −20°C. Protein pellets were 
collected subsequently by centrifugation (8000 g, 4°C), dissolved 
in 50 μL of 0.1 M TEAB and digested using 1 μL of trypsin (1 
mg/mL, Promega, USA); trypsin-to-protein ratio 1:35, at 37°C 
overnight. Tryptic digestion was stopped by acidification, by 
diluting the digested samples to a 0.5% (v/v) final concentration 
with formic acid. Peptides were reconstituted and desalted using 
Waters Sep-pack 50 mg C18 cartridges (Waters MA., USA) 
performing several washes of 0.1% (v/v) trifluoroacetic acid 
(TFA). Elution was carried out using 75% (v/v) acetonitrile, 0.1% 
formic acid and the eluted samples were concentrated using a 
vacuum concentrator. 
For the EVs proteomic analysis, 1 μg of tryptic peptides 
was separated on an Ultimate 3500 RSLS nanoflow system 
(Dionex, Thermo Fisher Scientific, USA) before online ESI-MS/
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MS analysis in a Q Exactive Plus mass spectrometer (Thermo 
Fisher Scientific, USA). For EV identification, direct injection 
onto a PepMap RSLC C18 analytical column (15 cm x 75 μm) with 
a linear gradient 5-35% mobile phase B [0.1% (v/v) formic acid in 
80% (v/v) acetonitrile] over 180 min at a flow rate of 300 nL/min 
was used to separate peptides. The MS instrument was operated 
using a Nanospray Flex ion source with a SilicaTipemitter (New 
Objective, China). The ionization voltage was set to 1.9 kV and 
the ion transfer capillary temperature to 275°C. MS was operated 
in positive ion mode using FT HCD MS2 [44]. Full scan FTMS 
spectra were acquired in range from m/z 380.0 to 1800.0 with 
a resolution of 60,000. 
Three most intense peaks from MS spectrum were selected 
for each fragmentation mode. The HCD MS/MS scan was 
fixed to start from m/z 100 with a resolution of 15000 using 
MS2 AGC target of 5 x 104. The collision energy was set as 
40% NCE and isolation window to ± 1.5 Da. Every precursor 
ion was repeated twice within a duration time of 30s and was 
excluded for 20 s. Precursor ions with unassigned charge state, 
as well as charge states of +1 and more than +7 were excluded 
from fragmentation. For peptide identification and relative 
quantification, the SEQUEST algorithm implemented into 
Proteome Discoverer (version 2.0, Thermo Fisher Scientific, 
USA) was used. 
Database search against Bos taurus FASTA files downloaded 
from NCBI database (6,347,539 entries) was performed according 
to the following parameters: two trypsin missed cleavage sites, 
precursor and fragment mass tolerances of 10 ppm and 0.02 Da, 
respectively; carbamidomethyl (C) fixed peptide modification, 
oxidation (M), deamidation (N,Q) dynamic modifications. 
The false discovery rate (FDR) for peptide identification was 
calculated using the Percolator algorithm in the Proteome 
Discoverer workflow based on the search results against a decoy 
database and was set at 1% FDR. Only proteins with at least two 
unique peptides were reported as reliable identification.
For the analysis of the proteomic data a matrix compatible with 
the program MetaboAnalyst 4.0® (https://www.metaboanalyst.
ca/) was constructed. The spectral counts were normalized for 
each protein identified by the weighted average of the triplicates 
of each sample [45]. Proteins that have been identified in less than 
40% of the samples were excluded from the analysis. Principal 
component analysis (PCA) and partial least squares (PLS) were 
used as the main method of multivariate analysis. Only signals 
present in 80% of the samples were considered for the generation 
of statistical models. 
Proteins were subjected to enrichment analysis for Gene 
Ontology (GO) terms “molecular function”, “biological process” 
and “cellular component” using PANTHER software (http://
www.pantherdb.org/ – version 13.1). Protein interactions were 
also investigated in regard to their biological processes using 
the STRING software (http://string-db.org/ - version 10.5) by 
using the basic parameters: cut-off score of 0.90, confidence as 
network edges and PPI enrichment p-value of < 1.0e-16.
Results
Theileriosis Diagnosis
Theileria disease is caused by an obligate intracellular parasite, 
transmitted by a tick vector to the mammalian host (Figure 1A 
and 1B) [46]. Despite disease diagnosis through the conventional 
microscopy methodology, PCR detection methods are currently 
considered as a superior alternative to identify parasite DNA in 
host blood [47]. Of the 57 animals evaluated, 11 tested positive for 
Theileria spp., four for Babesia bovis and five for both parasitic 
species. PCR assays corroborated the blood culture results. Based 
on these results, three experimental groups were composed: 
C – control animals or Theileria spp. negative animals (n = 3); 
Th – Theileria spp. positive animals (n = 2) and ThT – treated 
animals or Theileria spp. negative animals after contact with 
parasite and treated with dibenzamidine diacetate (Ganaseg® 
Plus) (n = 3). 
DNA quantification in serum samples indicated a concentration 
of more than 40 µg/mL in Theileria spp. positive animals and 
its concentration near of 0 µg/mL in control animals. Animals 
treated during three months with dibenzamidine diacetate 
showed a significant decrease in DNA amount, revealing the 
efficiency of treatment (Figure 1C).
Isolation and Characterization of EVs
Given the confirmation of presence and/or absence of Theileria 
DNA, we further evaluated the serum samples from buffaloes 
regarding the presence of EVs. The serum was centrifuged at 
4200 × g for 10 min at 22C. Serum from the three experimental 
animal groups were fractionated by Izon qEV size-exclusion 
chromatography columns (Izon Science, UK) (Figure 2A), 
resulting in five fractions of 500 µL (F1 to F5). All fractions 
were analyzed by western blotting (data not shown) and fractions 
F2 and F3 showed signals corresponding to the specific EV 
markers: flotillin-1 (cytosolic protein recovered on EVs) and 
CD9 (transmembrane protein associated with endosomes). 
Western blotting (WB) analyses have confirmed the efficiency 
of EV purification (Figure 2B). The F3 fractions from control 
animals (C), Theileria spp. positive animals (Th) and treated 
animals (ThT) were submitted to nanoparticle tracking and 
transmission electron microscopy analysis (Figure 2C). The 
vesicles present in fractions had sizes ranging from 140.2 nm for 
control animals, 124.0 nm for Theileria positive animals (Th) to 
138.8 nm for treated animals (ThT), which is compatible with 
EV sizes, confirming the quality of purified vesicles (Table 1).
Detection of Flotillin and CD9 in EVs
Flotillin is a cytosolic protein that is found in EVs due to its ability 
to bind to membranes. This protein is considered a canonical 
marker for EVs. We have detected flotillin-1 on fractions F2 
and F3 obtained from EV purification in the control animals 
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Figure 1. Theileria spp. found in infected animals. (A) Bubalus bubalis buffaloes and (B) photomicrography of the Theileria spp. parasite. (C) DNA quantification 
showing a reduction of Theileria spp. DNA upon dibenzamidine diacetate treatment.
Figure 2. Isolation and characterization of EVs from buffalo serum. (A) Izon qEV size-exclusion chromatography columns. (B) Western blotting of Fractions 2 
(F2) and 3 (F3) to the EV markers flotillin-1 and CD9 in control animals, Theileria spp. positive animals and treated animals. (C) Nanoparticle tracking analysis and 
transmission electron microscopy analysis in Fraction 3. (D) Densitometry of WB bands of Fraction F3.
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(C), Theileria spp. positive animals (Th) and treated animals 
(ThT) (Figure 2B). To determine whether the amount of this 
protein varied among the groups, we quantified WB bands 
by densitometry, which revealed that f lotillin-1 increased 
significantly in Theileria spp. positive animals when compared 
with controls. Interestingly, after treatment with dibenzamidine 
diacetate, the levels of this marker decreased in treated animals, 
being comparable with the control animals, as can be seen in 
Figure 2D. The CD9 tetraspanin membrane protein is another 
EV marker that was detected in F2 and F3 samples. This protein 
was also increased in Theileria spp. positive animals. However, 
its levels did not decrease upon treatment with dibenzamidine 
diacetate; on the other hand, they increased in treated animals, 
as shown in Figure 2D.
Proteomic Analysis 
A total of 306 proteins were identified and analyzed in fraction 
F3 of controls, Theileria spp. positive and treated animals. 
Such proteins are listed in the Additional files 1, 2 and 3. Gene 
ontology (GO) enrichment analysis have evidenced 217 genes 
involved in the protein expression, in which 19 protein classes 
can be distinguished: enzyme modulator, cytoskeletal protein, 
hydrolase, signalling molecule, oxidoreductase, defense protein, 
receptor, transferase, carrier protein, extracellular matrix protein, 
transport, lyase, cell adhesion molecule, structural protein, 
calcium-binding protein, storage protein, isomerase, chaperone 
and surfactant (Figure 3A). GO annotations “biological process”, 
“molecular function” and “cellular component” are shown in the 
Figures 3B, 3C and 3D, respectively. Additionally, the protein-
protein interaction map provided a better understanding of 
the relationship among the proteins present in extracellular 
vesicles from buffalo serum (Figure 4 and Figure 5). The major 
Reactome pathways can be distinguished into membrane 
trafficking of small molecules; vesicle-mediated transport and 
signal transduction (Figure 6).
PCA and PLS analysis (Additional file 4) of the samples 
revealed statistical differences between control animals and 
Theileria spp. positive buffaloes whereas treated animals 
were considered similar to the control animals. It is possible 
to observe that only PCA was not sufficient to distinguish 
Theileria positive from control animals. Conversely, the PLS 
analysis satisfactorily divided the groups. Five proteins showed 
differential expression between controls and Theileria positive 
animals (Additional files 5 and 6): creatine kinase U-type 
(code access: Q9TTK8), L-lactate dehydrogenase A chain (code 
access: P19858), L-lactate dehydrogenase (code access: B0JYN3), 
L-lactate dehydrogenase (code access: Q5E9B1), and betaine-
homocysteine S-methyltransferase 1 (code access: Q5I597). The 
ESI-MS/MS data were deposited in the PeptideAtlas repository 
(http://www.peptideatlas.org/PASS/PASS01243) with the dataset 
identifier PASS01243.
Table 1. Nanoparticle tracking analysis of extracellular vesicles obtained from Bubalus bubalis sera found in F3 fractions isolated from control animals, Theileria 
spp. positive animals and treated animals (± standard error). Values are represented in nanometers (nm).
Read 1 Read 2 Read 3 Average Standard  deviation
Control animals
Mean 154.1 133.5 133.0 140.2 6.9
Mode 67.0 58.1 42.9 56.0 7.0
SD 97.2 86.6 82.1 88.6 4.5
D10 58.4 50.2 38.7 49.1 5.7
D50 133.6 103.4 130.1 122.4 9.5
D90 279.6 259.9 235.1 258.2 12.9
Theileria spp. positive
Mean 125.6 116.4 130.0 124.0 4.0
Mode 88.5 29.0 78.3 65.3 18.4
SD 71.9 70.5 63.6 68.7 2.6
D10 42.9 30.3 63.6 45.6 9.7
D50 93.4 97.6 110.1 100.3 5.0
D90 217.1 209.0 223.1 216.4 4.1
Treated animals
Mean 149.9 138.0 128.6 138.8 6.2
Mode 132.5 91.1 109.3 111.0 12.0
SD 52.1 50.0 41.7 47.9 3.2
D10 102.4 82.7 78.8 88.0 7.3
D50 128.4 121.3 106.2 118.6 6.5
D90 232.1 226.0 190.4 216.2 13.0
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Figure 4. Interaction network among major proteins identified in EV from buffalo serum. The circles represent proteins while the straight lines represent the 
interactions among different proteins. The stronger associations are represented by thicker lines. 
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Figure 5. Main biological processes and molecular functions: dark green circles indicate cellular metabolic processes; yellow circles show transport; purple ones 
designate catalytic activity, light green circles mark binding whereas red ones represent the proteins involved in the response to stress. 
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Figure 6. Principal Reactome pathways: yellow circles indicate the proteins involved in transport of small molecules; green circles represent membrane 
trafficking; purple ones show vesicle-mediated transport and red circles depict proteins involved in signal transduction. The protein network was analyzed using 
STRING software and the associations between proteins were detected using the Kyoto Encyclopedia of Genes and Genomes (KEGG) tool. 
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Discussion
Extracellular vesicles (EVs) are spontaneously released from 
cells, but their production may be higher or lower depending 
on the infection. They have been increasingly studied for 
their mechanism of intercellular communication and may 
be of particular significance in infectious diseases. EVs can 
potentially benefit the host immune response or promote 
alternative pathways for pathogen survival [48]. The present 
results corroborate previous findings describing EVs as players in 
parasite-host interactions [48,49]. We are aware of the challenges 
of studying EVs and, in this aspect, we emphasize that one 
of the limitations of the present study, also reported in the 
literature, refers to the low number of samples due to the high 
costs of analysis. 
Despite the knowledge about differences in their biogenesis 
and function, differentiation between exosomes and EVs is 
not always possible, so that a consensus and establishment of 
standardized methods is necessary to provide more reliable and 
interchangeable premises among studies [50–52].
The apicomplexan phylum is composed of more than 6,000 
named species, including genera of clinical and/or economic 
importance in human and veterinary medicine. Apicomplexans 
cause human malaria (Plasmodium spp.), theileriosis 
(Theileria spp.), coccidiosis (Eimeria spp.), cryptosporidiosis 
(Cryptosporidium spp.) and toxoplasmosis (Toxoplasma gondii). 
In fact, all animal species are believed to serve as host to at least 
one Apicomplexan species [53]. Theileriosis is a tick-borne disease 
that has historically caused great economic losses in the farming 
industry. Theileria species causes many diseases in livestock: 
corridor disease (T. parva), East Coast fever (T. parva), tropical 
theileriosis (T. annulata) in cattle and malignant theileriosis 
(T. lestoquardi) in goats and sheep [54]. Affections caused by 
apicomplexan parasites are also considered emerging zoonoses 
[11,13,15,55,56]. 
This communication evidenced the isolation and enrichment of 
EVs in Theileria infections in buffaloes, confirming the literature 
data about EVs in parasitic infections [57]. Isolation of vesicles 
was conducted by means of size exclusion chromatography and 
identification of EVs was assessed through western blotting by 
the presence of tetraspanin CD9 and membrane lipids raft-
associated Flotllin-1 [4]. These markers are compatible with 
validated studies of exosomes; however, they are not specific for 
exosomes and could represent other types of EVs, thus being 
referred to as exosome-like due to the presence of microvesicles 
after size-exclusion [58].
These results remarkably suggest that for exosome-like vesicles 
isolation using size exclusion chromatography columns, the 
third fraction (F3) contain the higher number of vesicles, and 
should be assessed for further analysis, in agreement with the 
literature [58]. Despite the fact that ultracentrifugation (UC) 
remains the most frequently used primary isolation technique 
for EVs, vesicles isolated by UC are known to suffer from 
non-vesicular macromolecule contamination and vesicular 
aggregation, hampering omics and functional analysis. For 
this reason, UC is often combined with other purification 
techniques, which implies in more time-consuming protocols 
[58,59]. The use of size-exclusion chromatography and other 
chromatographic techniques (e.g. HPLC) was recently validated 
and it is increasingly used to isolate Evs, since it provides 
lower contamination with macromolecular complexes than 
ultracentrifugation. Nevertheless, different isolation techniques 
might isolate different EV subpopulations, so that, identifying 
surface markers of a certain subpopulation would be required to 
achieve the highest purity, such as affinity-based isolations [60].
Our results showed an increase in flotillin quantification in 
EVs of Theileria spp. positive group in comparison to control, 
and a decrease of this protein as a result of a treatment with the 
drug Ganaseg® Plus. Although we understand the necessity of 
further investigation about the relationship of EVs with Theileria 
infections, these results can be considered as a first evidence 
on the contribution of EVs in parasitic diseases, and more than 
that, suggest that the amount of EVs is positively related with 
the degree of infection. 
This hypothesis is supported by the literature data 
demonstrating the increase of exosomes followed by parasite 
load increases. This can be explained by the assumption that 
exosomes carry genes responsible for essential mechanisms for 
the disease development (parasite-host) such as sustain itself 
for a longer time, increasing consecutively the infection time 
[52]. Over the past three decades, many proteomics studies 
performed on EVs have elucidated their diverse roles exerted 
by theses vesicles. 
The protein-protein interaction analysis from buffalo blood 
vesicles has evidenced biological and molecular processes 
associated with binding, regulation of metabolic processes, 
transport, catalytic activity and response to stress. Besides, 
it was possible to Reactome pathways as signal transduction, 
transport of small molecules, membrane trafficking and vesicle-
mediated transport.
The PLS results suggest that extracellular vesicles from 
affected animals can be distinguished from those of healthy 
ones by presenting lactic acid that is related to the reduced use 
of pyruvate in the tricarboxylic acid cycle and the increase of 
anaerobic glycolysis [61–62]. Lactate may also result from the 
activated lactate dehydrogenase, which results in increased 
oxidative stress [63–65]. Creatine was also markedly increased 
in unhealthy animals, leading to adverse changes and serious 
damage to renal function [66]. Since this compound is thought 
to exert direct antioxidant effects [67,68], its increase may 
reflect a protective mechanism against the enhanced oxidation 
[69,70], corroborating the data obtained in the Gene Ontology 
enrichment analysis and protein-protein interaction network 
shown in Figures 3 and 4. There are few descriptions about 
these pathways and their role in EVs derived from infected 
environments. Additional studies should be done over the years 
conducting to better elucidations about the extracellular vesicle 
pathways in protozoan parasites. 
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Based on the described results, we suggest that Theileria 
parasites may use EVs as important pawns in their infection 
processes. The real role of these vesicles is still unclear; however, 
their presence, as well as their increase in blood from unhealthy 
animals highlight a possible new approach to understand parasite-
host relationship. Specifically, for Theileria spp. infections, given 
the importance of buffalos for the production of human and 
veterinary health products, we can assume that our data strongly 
contribute to a future development of an improved diagnostic 
tool that could bring economic and public health advantages. 
Conclusion
For the first time EVs from buffalo blood infected with Theileria 
spp. were successfully isolated and characterized. This is 
an advance in the knowledge of host-parasite relationships 
contributing to understanding the evasion mechanisms of the 
parasite. These findings may pave the way for the search of 
new EV candidate-markers aiming to a better management of 
buffaloes to produce safe biologicals. Further steps are strongly 
encouraged in relation to expanded EVs studies in Apicomplexa 
infections in animals.
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